pharmaphorum August 15, 2022
Adam Hutchinson, founder of oVRcome, discusses the weight the New Zealand-based company places on ensuring the accuracy and effectiveness of its virtual reality (VR) treatments through clinical trials.
A recent study revealed that most mental health apps lack scientific backing to verify their claims, but Hutchinson says oVRcome ensures its platform – which provides VR exposure therapy for patients with phobias is effective by working directly with clinical psychologists and performing clinical trials to verify results.
“We realise how important [clinically proven treatments] are for people. At the end of the day, we’re a startup that no one knows on the other side of the world using virtual reality, a technology that not many people understand. That’s why it...
Today's Sponsors
Today's Sponsor